Poll Finding

For-Profit Health Care Companies: Trends and Issues – Fact Sheet

Published: Feb 11, 1998

The rapid growth of managed care has brought with it a growing connection between the stock market and health care organizations. Health care services have evolved from being delivered by physicians and tax exempt institutions to a market-driven industry attracting investment capital from numerous sources. The market capitalization, or total stock value, of the relatively young HMO industry grew from a little over $3 billion in 1987 to almost $39 billion in 1997 – an almost twelve-fold increase – while the stock market as a whole grew about four-fold to a total of $10.5 trillion. However, recent health plan earnings announcements indicating companies’ difficulties in managing medical costs have led some equity analysts and investors to question whether these health sector stocks will offer growth potential in the future.

Some health care providers, policy-makers, and consumer advocates question whether it is appropriate that profit motives and goals to maximize stock values drive changes in the health care system. They argue that the types of decisions that ensure shareholder value are not necessarily the same as those that would guarantee quality health care. On the other hand, many industry representatives and investors credit market incentives and for-profit companies with fundamentally restructuring health services in a manner that has promoted efficiency and entrepreneurship in an industry in need of change.

The Growing Influence of For-Profit Organizations

jmf_chart1.gif

The increased corporate influence in health care is especially evident in the growing prevalence of for-profit companies within the HMO sector. Between 1981 and 1997, for-profit HMOs grew from representing 12% to 62% of total HMO enrollees, and from 18% to 75% of plans (Interstudy). Among hospitals, on the other hand, for-profit companies have increased their role, but nonprofit organizations continue to dominate the industry. Between 1981 and 1995, for-profit companies grew from representing 9% to 12% of community hospital beds, and from 13% to 14% of community hospitals (American Hospital Association data).

Total market capitalization of HMOs grew from $3.3 billion in January 1987 to $38.9 billion as of the end of November 1997, an almost twelve-fold increase.The growing role of for-profit companies in the HMO and hospital sectors has resulted from a combination of the emergence and growth of for-profit companies, as well as conversion of not-for-profit companies to for-profit status. One implication of these conversions is the establishment of charitable foundations designed to preserve the charitable missions and assets of the formerly not-for-profit organizations. As of September 1, 1997, there were 81 conversion foundations in the U.S., with assets totaling $9.3 billion. Health plan conversions represented the source of only 12 of the foundations, but these foundations hold almost half of the total assets (Grantmakers in Health).

Stock Trends

Many for-profit health services and HMO companies have tapped the stock market for financing. According to an analysis prepared for the Kaiser Family Foundation by Securities Data Company, there were 233 initial public offerings (IPOs) of stock of health services and HMO companies between 1987 and 1997.

The total stock value (or market capitalization) of publicly traded health services and HMO companies has increased dramatically over the past decade. Total market capitalization of HMOs grew from $3.3 billion in January 1987 to $38.9 billion as of the end of November 1997, an almost twelve-fold increase. For companies classifying themselves as health services, capitalization grew from $16.3 billion to $112.7 billion over the same time frame. In comparison, the overall stock market grew a little over four-fold during this time period. Wall Street’s growing interest and role in health care companies is also evidenced by the increased number of investment analysts following health care stocks – from 152 in 1987 to 559 in 1997, according to Nelson’s Directory of Investment Research.

jmf_chart2c.gif

Over the last decade, HMO stocks have generally out-performed the market as a whole, although these companies experienced significant price declines between March and August 1995, between April and July 1996, and between July and November 1997. Health services companies have tracked somewhat above the market through much of the decade, but the ten-year return for the overall market and health services companies is equal. Using a University of Chicago index that measures the market-weighted return of stocks, a 1987 investment of $100 in the market as a whole or in health services companies would have grown to $492 by the end of November 1997. In comparison, an investment of $100 in HMOs would have grown to $821.

Recently, average annual returns for health services and HMO companies have suffered relative to the overall market. While the market has achieved record levels, these health companies have experienced some notable difficulties.

jmf_chart3a.gif

Recent Events

Recent public announcements highlight anxiety among those on all sides of the question about the appropriate role for the stock market within the health services industry. Investors who were bullish on health care stocks in the past voted with their portfolios after being surprised by recent bad news from some of the largest and best-performing publicly traded health care companies. The largest publicly traded HMO, Aetna/U.S. Healthcare, suffered a greater than 10% decline in its stock price in December 1997 over the two days following an announcement that its chief financial officer would be stepping down amid rumored problems in managing the post-merger operations of U.S. Healthcare.

jmf_chart4.gif

Oxford Health Plan lost 75% of its stock market value between late October 1997 and the end of the year, when the company disclosed a charge to earnings stemming from accounting and computer problems affecting estimates of medical care costs and payments due to providers. Some also point to Oxford

National AIDS Treatment Information Project

Published: Feb 1, 1998
natip.gif

Viral Load Testing

What does viral load mean?

Viral load (or viral burden) refers to a measurement of the number of HIV particles. The total viral load is the amount of HIV in your blood, lymph nodes, spleen, and other parts of your body. If your viral load measurement is high, it indicates that HIV is reproducing and that the disease will likely progress faster than if your viral load is low.

What is viral load testing?

Viral load testing measures the number of HIV particles in your blood. These tests detect a kind of protein strand called RNA, which is a part of HIV containing the genes of the virus. Each HIV particle contains two copies of a molecule called RNA that carries the HIV genes. The viral load test determines the number of copies of HIV RNA molecules in a sample of blood.

There are three laboratory techniques that have been developed for viral load testing: quantitative polymerase chain reaction (PCR), branched-chain DNA (bDNA), and nucleic acid sequence-based amplification (NASBA). While the viral load test actually measures only the level of virus circulating in your blood, there is evidence that this value is a good indicator of the amount of virus in your entire body.

How is viral load testing helpful?

Your viral load test result provides important information that is used in conjunction with your CD4 cell (“T-cell”) count to monitor the status of HIV disease, to guide recommendations for therapy, and to predict its future course. While the CD4 count is a marker of the health of your immune system (high value is better), viral load testing directly measures the number of HIV particles circulating in your blood (low value is better). There is good evidence that keeping the viral load titer “as low as possible for as long as possible” will decrease the likelihood of developing complications of HIV disease and will prolong life.

What do the results of a viral load test mean?

Viral load tests are reported as the number of HIV “copies” in a milliliter of blood. Results can generally be classified as high, low, and intermediate. General guidelines for understanding the results follow:

  1. High viral load: greater than 5,000 to 10,000 (five thousand toten thousand) copies. This result indicates a higher risk for HIVdisease progression. High viral load titers may range as high asone million copies or more.
  2. Low viral load:
  3. less than 200 to 500 (two hundred to fivehundred) copies depending upon assay used. This result indicatesthat HIV is not actively replicating and that the risk of diseaseprogression is low. It is important to realize that an”undetectable” test result does not mean that HIV infection iscured. Rather it indicates that the level of virus in the blood islower than the test can measure.

Viral load titer results between these values (less than 5,000 to10,000 but greater than 200 to 500) are considered intermediate.

How is viral load testing used in managing HIV disease?

Doctors and researchers are still trying to determine how viral load testing should be best used for patient care. Most believe that viral load tests can be used to determine when to begin antiretroviral (anti-HIV) therapy and whether the drugs you are receiving are effective. In general, antiretroviral therapy is recommended in persons with high viral load titers regardless of their CD4 count results or whether they have any symptoms. In persons with intermediate viral load titers, either starting drug therapy or monitoring them off therapy may be reasonable options. If well tolerated, antiretroviral drugs are continued as long as they suppress the viral load titer.

When and how often should viral load testing be performed?

Recommendations about how to use viral load testing probably will change as researchers learn more about the test and doctors gain more experience with it. The following are general guidelines:

BaselineInitially it is a good idea to have two viral load tests performed at separate visits. This will give a reliable measure of the baseline HIV level. If your viral load is low and CD4 count is normal, your doctor may not recommend antiretroviral therapy. If your viral load is high, your doctor will recommend that you start antiretroviral therapy.

Evaluating therapyTo determine if antiretroviral therapy is effective, you should have a viral load test performed along with a CD4 count about four weeks after starting it. In general, effective therapy should result in a significant drop in your viral load titer over this time period. This is defined as at least a factor of three-fold (for example from 10,000 to less than 3,000). Your doctor will review the results with you and discuss the significance of the change in viral load titer.

Monitoring therapyYou should have a viral load test along with a CD4 count performed every three to four months to confirm that the antiretroviral drugs you are receiving continue to keep your viral level low. To provide accurate comparisons, your doctor will send all the viral load tests to the same laboratory and have your blood samples analyzed by the identical technique. In general, viral load testing should not be performed during a new illness or soon after a vaccination, as both of these may temporarily affect the results.

Teen Pregnancy: Key Statistics

Published: Jan 31, 1998

The Henry J. Kaiser Family Foundation

header.gif

girlin.gifwidespread.gifHow widespread is teen pregnancy in the U.S.? More than four in 10 young women become pregnant at least once before they reach the age of 20 – nearly one million a year. increase.gifAre more teens getting pregnant today than two or three decades ago? The pregnancy rate among all teen girls aged 15-19 rose 23 percent between 1972 and 1990, and then fell slightly in 1992. This increase occurred because of a rise in the proportion of teenagers who have had sexual intercourse. During the same time, the pregnancy rate among sexually experienced teen girls decreased 19 percent, largely due to the fact that many more teens use contraception today than did in the past. Most (71%) sexually active teens use contraception.

Are most teen pregnancies planned?No. The overwhelming majority-78 percent-of pregnancies to 15-19 year old teen girls are not planned. Among younger teens, 15-17 year olds, 83 percent of pregnancies are unplanned. Back Next

Return to top

“The More You Know About Teen Pregnancy Prevention”Press Release Teen Pregnancy Key Statistics

Poll Finding

Kaiser Family Foundation Survey of Americans about Health Care and the Stock Market

Published: Jan 31, 1998

A survey on Americans’ perceptions of healthcare stocks and the differences between for-profit and nonprofit healthcare organizations. A fact sheet including data on financial trends from the past decade is included. This survey was released at a briefing held jointly by the Kaiser Family Foundation and the National Press Foundation for journalists on February 11 entitled Do Falling Stocks Mean Failing Care? Trends and Implications of Wall Street’s Declining Healthcare Stocks. The event is part of an ongoing series: MarketWatch: A Briefing Series for Journalists on Changes in the Health Care System.

National Campaign to Prevent Teen Pregnancy: The More You Know About Teen Pregnancy Prevention Campaign Information

Published: Jan 31, 1998

The Henry J. Kaiser Family Foundation

header.gif

subway.gifcouple.gifsources.gifWhen are teens most likely to get pregnant? Pregnancy risk is high right from the beginning of sexual activity: half of all first teen pregnancies occur in the first six months after sexual activity begins. mostpregnant.gif

mostteen.gif

What are the outcomes of most teen pregnancies?Half (54%) of pregnancies among teen girls, 15-19 years old, end in birth. A third of teen pregnancies end in abortion (32%) and 14 percent end in miscarriage. Who are teen mothers?Three quarters (76%) of teen mothers are unmarried and 60 percent are 18-19 years old.

What do teens say they need to know about preventing pregnancy?Most teens say information about sex and pregnancy prevention often comes “too late” and doesn’t have enough basic facts about contraception.

Do other countrieshave as many teen pregnancies and births as we do? No. The teen pregnancy rate in the United States is the highest of any industrialized democracy, nearly twice that of Great Britain and 10 times that of Japan.

usrate.gif

Back Return to top

“The More You Know About Teen Pregnancy Prevention”Press Release Teen Pregnancy Key Statistics

Medicare Beneficiaries and HMOs: Highlights of Los Angeles and New York City Medicare HMO Markets

Published: Jan 30, 1998

A growing number of Medicare beneficiaries are enrolling in Medicare HMOs as an alternative to the traditional Medicare program. However, Medicare HMO enrollment has not grown uniformly in market areas across the country. Case studies conducted by researchers at Mathematica Policy Research, Inc. for The Kaiser Family Foundation describe the evolution of Medicare managed care in the two largest markets in the United States: Los Angeles County and New York City. The reports also discuss the impact of the shift to Medicare managed care on Medicare beneficiaries, plans, and providers in each of the respective markets.

Setting Capitation Rates for HIV/AIDS Care:  A Primer for Ryan White CARE Act Title IV Project

Published: Jan 30, 1998

Setting Capitation Rates for HIV/AIDS Care: A Primer for Ryan White CARE Act Title IV Project

  • Report: Setting Capitation Rates for HIV/AIDS Care: A Primer for Ryan White CARE Act Title IV Projects

National ADAP Monitoring Project: Interim Technical Report

Published: Jan 30, 1998

National ADAP Monitoring Project: Interim Technical Report

This interim technical report provides an update on the status of ADAP programs as of September 1997. It updates a Kaiser Family Foundation report from July 1997.

Report (.pdf)

State Facts: Health Needs, and Medicaid Financing

Published: Jan 30, 1998

This data book provides a profile of selected indicators of health needs, insurance coverage, and the role of Medicaid in each state with comparative statistics for the United States.